About Glivec International Patient Assistance Program(GIPAP)

The largest of Novartis’ Oncology Access programs – the Glivec International Patient Assistance Program (GIPAP) is a direct-to-patient access program – developed to ensure patients with CML (chronic myeloid leukemia) or GIST (gastrointestinal stromal tumour), two rare cancers, receive treatment.

GIPAP’s aim is to provide breakthrough drug, Glivec, at no cost to patients with certain forms of CML and GIST, who would not otherwise have access to treatment. GIPAP also provides patients with access to support groups, treatment and disease information, education and emotional support to help manage their illness. More than 60,000 patients from 80 countries have benefi­tted from GIPAP to date, the program is viewed as one of the most comprehensive and far-reaching cancer access programs ever developed on a global scale.

 

Partners in GIPAP

Novartis partners with physicians and international health organizations to facilitate access to Glivec via GIPAP. To reach as many CML and GIST patients in need as possible in low and middle income countries, GIPAP partners have established clear roles for the partners and a clear process for the program, engaged local governments and officials, and educated local partners to gain their support and commitment. The Partners are Max Fountation,Axios International,Novartis

The Max Fountation
  • Manages a system that enables GIPAP physicians to submit patient cases for approval and re-approval
  • Assesses submissions to approve patients according to program requirements
  • Assesses the number of patients in need so Novartis can ship the correct quantity of drugs
  • Provides emotional support to patients and families involved in GIPAP through local Max station representatives
Axios International
  • Supports interaction with GIPAP physicians and institutions in countries where Novartis does not have a presence
  • Manages the drug import process in countries supported by GIPAP
  • Interacts with GIPAP institutions on a regular basis to ensure that they follow correct procedure
Novartis
  • Ensures the timely shipment and distribution of the drug
  • Provides training, support and education to the parties involved
  • Manages a tracking process to guarantee the correct use of the donations 

Make a single or monthly donation today

The largest of Novartis’ Oncology Access programs –

Countries

80

Volunteer

1200

Donator

201

Raised Funds

200

Run it forward official charity

Every day we bring real hope to millions of children in the world’s hardest places as a sign of God’s unconditional love

Run it forward official charity

Every day we bring real hope to millions of children in the world’s hardest places as a sign of God’s unconditional love